Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00742014Phase 3Terminated
Phase 3, open-label, single-arm trial of ASP-001 in pulmonary arterial hypertension (PAH), sponsored by SickKids. Primary endpoint: Increase in endsystolic elastance of the right ventricle from baseline. Started Aug 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00742014.